Sunday, November 10, 2024
64.3 F
Oxnard
More

    Latest Posts

    Setting Brushfires of Freedom by Don Jans

    District Attorney Alerts Community to New Price Gouging Executive Order

    District Attorney Gregory D. Totten wishes to alert county residents of a new Executive Order by Governor Gavin Newsom regarding price gouging. Pursuant to Executive Order N-44-20 issued April 3, 2020, retailers may not charge a price that is ten percent greater than the price that they charged on February 4, 2020, for food, consumer goods, medical supplies, emergency supplies, or any other materials previously designated by the United States Secretary of Health and Human Services as Scarce Materials or Threatened Materials pursuant to section 102 of the Defense Production Act, 50 U.S.C. § 4512. However, consistent with the language of Penal Code section 396, retailers may charge more if their costs recently increased, or if they offered a reduced price as of February 4, 2020, they may charge their ordinary price for the item.

    Pursuant to the Executive Order, persons or businesses who are now selling items listed above that they did not sell as of February 4, 2020, are now subject to a price cap. If the item was purchased, the price cannot exceed the cost of the item plus a markup of fifty percent of the cost. If the item was produced, the price cannot exceed the cost to produce and sell the item plus fifty percent of that cost. A violation of either of these provisions is a misdemeanor punishable by six months in jail or a $1000 fine, or potentially by both jail and fine. Violators may also be subject to a civil enforcement action resulting in civil penalties, restitution, and injunctions. Alleged price gouging violations may be reported by calling the District Attorney’s Office at (805) 662-1737, or by sending an email to [email protected].


    Get Citizensjournal.us Headlines free  SUBSCRIPTION. Keep us publishing – DONATE

    - Advertisement -

    1 COMMENT

    0 0 votes
    Article Rating
    Subscribe
    Notify of
    guest

    1 Comment
    Newest
    Oldest Most Voted
    Inline Feedbacks
    View all comments
    Citizen Reporter
    4 years ago

    That would mean that most pharmaceuticals are in violation, depending on whether it is based upon manufacturer’s cost or distributor’s price. Methods of overhead allocation and assignment of R&D approval costs also factor in.

    Latest Posts

    advertisement

    Don't Miss

    Subscribe

    To receive the news in your inbox

    1
    0
    Would love your thoughts, please comment.x
    ()
    x